Manisha Tripathi, Ph.D., helped lead a TTUHSC study focused on uncovering the molecular and signaling mechanisms that drive the progression of advanced prostate cancer.

Srinivas Nandana, Ph.D., helped lead a TTUHSC study focused on uncovering the molecular and signaling mechanisms that drive the progression of advanced prostate cancer.

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In ...

If detected early, cancer is much easier to treat. Emerging non-invasive tests can help early diagnosis. As diseases go, cancer is deadly. Its early detection, however, can make a huge difference to ...

The therapies are poised to revolutionize the cancer care landscape, but it will require collaboration across the industry, ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers ...

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

Discover how isodose MHFRT offers comparable cancer control to CFRT with fewer gastrointestinal side effects, improving patient outcomes.

Auburn Coach Hugh Freeze is wearing two hats during the Tigers' 2025 spring practice. That's not unusual. An SEC coach has to be good at multi-tasking. But in t ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.